Vertex Pharmaceuticals Inc. announced today that it submitted a New Drug Application to the U.S. Food and Drug Administration for the approval of the first triple-combination therapy for cystic fibrosis.
Site Search
Showing 31 - 40 of 50 results
News
|
Aug. 1, 2008
|
1 min read
News
|
July 22, 2019
|
1 min read
News
|
July 15, 2008
|
1 min read
News
|
Jan. 20, 2010
|
1 min read
News
|
Aug. 31, 2012
|
1 min read
The U.S. Food and Drug Administration (FDA) has approved TOBI® Podhaler™ (tobramycin inhalation powder), a dry powder formulation of the antibiotic TOBI, to treat lung infections caused by the bacteria Pseudomonas aeruginosa (P. aeruginosa).
News
|
March 25, 2013
|
1 min read
The U.S. Food and Drug Administration (FDA) announced that it has approved Ultresa™ delayed-release capsules, a pancreatic enzyme replacement therapy. Ultresa (pancrelipase) is manufactured by Aptalis Pharma.
News
|
March 2, 2012
|
1 min read
News
|
May 4, 2009
|
2 min read
News
|
Dec. 28, 2007
|
2 min read
News
|
Dec. 15, 2009
|
2 min read